Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS: Phase 2 study closed enrollment, 19 enrolled (Stage IV Colorectal Cancer, Curative Resection)
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS: Phase 2 study closed enrollment, 19 enrolled (Stage IV Colorectal Cancer, Curative Resection). Its enrollment of 19 is below the median of 80 (8th percentile). Dated 9 days ago, it is in the active follow-up window. Score 70/100. As of 2026-11-05, from ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
enrollment: 19 · 8th percentile of 9,177 ClinicalTrialStartPulse records · 0.2x the median
Free preview: all 15 published fields of this record are shown below. Locked: 499 related ClinicalTrialStartPulse records and the 7-column CSV export.
| Field | Value |
|---|---|
| Sponsor | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS |
| Sponsor type | Academic and hospital |
| Study | Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer. |
| NCT ID | NCT02919644 |
| Phase | Phase 2 |
| Status | active not recruiting |
| Conditions | Stage IV Colorectal Cancer; Curative Resection |
| Intervention types | biological, drug |
| Target enrollment | 19 |
| Site countries | Italy |
| Posted | 2016-09-29 |
| Planned start | 2016-12-02 |
| Event | Enrollment closed (active, not recruiting) |
| Event date | 2026-10-28 |
| Last update posted | 2026-10-28 |
| enrollment percentile | 8th of 9,177 (median 80, 0.2x median) |
| Peer records CSV (500 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Unlock Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS + 500 peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Phase · Conditions · Enrollment · Countries · Event · Posted · official source URL
- Source agency: ClinicalTrials.gov (U.S. National Library of Medicine) API v2
- Record date: 2026-10-28
- Data refreshed: 2026-11-05
- Refunds on request within 14 days
Top ClinicalTrialStartPulse records (NONUS first): University of Oxford · DejthidaNathaphong · Eye & ENT Hospital of Fudan University · Shanghai First Maternal and Infant Health Hospital affiliate · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Browse all by state and category →
LIVE PUBLIC DATA Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 · Last refreshed: Thu, 05 Nov 2026 08:46:16 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS and 6,823 NONUS peers
- NONUS ClinicalTrialStartPulse records like this one: 6,823
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS's enrollment: 8th percentile of 9,177 records
- Timing: Medium: dated in the last 30 days
- Estimated pipeline if you contact every NONUS peer: $1,364,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
70 / 100 Score
- Posted in the last two weeks.
- Enrollment closed: data management, monitoring and closeout ahead.
- Phase 2: multi-site, larger budget.
What is the ClinicalTrialStartPulse record for Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS?
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS's Phase 2 study (NCT02919644) in Stage IV Colorectal Cancer, first posted 2016-09-29: enrollment closed (active, not recruiting) (2026-10-28), in an update posted 2026-10-28.
How does Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS compare to other ClinicalTrialStartPulse records?
Its enrollment of 19 is below the median (8th percentile); smaller records often move faster and face less competition. It is fresh: dated 9 days ago, inside the window where early outreach matters most. Its Score of 70/100 puts it among the stronger signals in this feed.
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | NONUS | 19 | 8th | 2026-10-28 |
| Tortugas Neuroscience, Inc. | NONUS | 100 | 60th | 2026-11-04 |
| Enlivex Therapeutics Ltd. | NONUS | 134 | 67th | 2026-11-04 |
| Genfleet Therapeutics (Shanghai) Inc. | NONUS | 150 | 71st | 2026-11-04 |
Related records
ClinicalTrialStartPulse: Phase 2 ClinicalTrialStartPulse: Outside the US only
How to monitor Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS and peer phase 2 records
Get new ClinicalTrialStartPulse records like Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.